Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pre-exposure Prophylaxis for Prevention of HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05813964
What this trial is testing

Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.

Who this might be right for
HIV/AIDS
ANRS, Emerging Infectious Diseases 524
Very early researchStudy completedNCT04898699
What this trial is testing

IPrEP Men's Study: Expanding the Reach of Prevention for Men in Kisumu, Kenya

Who this might be right for
HIV
Columbia University 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT06273943
What this trial is testing

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.

Who this might be right for
Prevention
ANRS, Emerging Infectious Diseases 322
Testing effectiveness (Phase 2)Active Not RecruitingNCT06513312
What this trial is testing

Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 268
Post-approval studies (Phase 4)Study completedNCT03194308
What this trial is testing

Safer Conception for Women - Understanding Use of Periconception PrEP

Who this might be right for
HIV PreventionConception
Massachusetts General Hospital 330
Post-approval studies (Phase 4)Active Not RecruitingNCT07210125
What this trial is testing

Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

Who this might be right for
HIV
Kelley-Ross & Associates, Inc. 75
Not applicableStudy completedNCT06566417
What this trial is testing

Social Media as a Risk Tool for HIV Prevention Needs

Who this might be right for
HIV PreventionHIV Preexposure Prophylaxis
Massachusetts General Hospital 400
Not applicableLooking for participantsNCT05326061
What this trial is testing

Vienna HIV Infection Via Sex Study

Who this might be right for
HIV InfectionsHIV Pre-Exposure ProphylaxisSexually Transmitted Diseases+3 more
Medical University of Vienna 500
Not applicableStudy completedNCT04897737
What this trial is testing

Postpartum Pre-exposure Prophylaxis (PrEP) Study to Evaluate an Adherence Promotion Package for Postpartum Women on PrEP

Who this might be right for
HIV-1-infection
University of California, Los Angeles 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT06101329
What this trial is testing

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 253
Testing effectiveness (Phase 2)Study completedNCT04692077
What this trial is testing

Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 9
Testing effectiveness (Phase 2)Study completedNCT02165202
What this trial is testing

Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis

Who this might be right for
Human Immunodeficiency Virus (HIV)
PATH 136
Large-scale testing (Phase 3)Study completedNCT04937881
What this trial is testing

PK of TAF and TDF for PrEP in Pregnant and Postpartum Women

Who this might be right for
Hiv
University of California, Los Angeles 39
Not applicableLooking for participantsNCT05774548
What this trial is testing

LA PrEP Impact and Cost-effectiveness (TEAMS)

Who this might be right for
Hiv
Institute of HIV Research and Innovation Foundation, Thailand 10,720
Large-scale testing (Phase 3)Active Not RecruitingNCT04925752
What this trial is testing

Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 3,292
Testing effectiveness (Phase 2)Study completedNCT06045507
What this trial is testing

Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)

Who this might be right for
HIVHIV Pre-exposure Prophylaxis
Merck Sharp & Dohme LLC 352
Not applicableStudy completedNCT01902472
What this trial is testing

A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada® for Pre-Exposure Prophylaxis (PrEP)

Who this might be right for
HIV
Gilead Sciences 172
Early research (Phase 1)Study completedNCT03270969
What this trial is testing

A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women

Who this might be right for
HIV Prevention
University of Nebraska 15
Not applicableEnrolling By InvitationNCT05492565
What this trial is testing

Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis

Who this might be right for
HIV Infection PrimaryHepatitis, Viral, HumanSexually Transmitted Infections, Excluding HIV and Hepatitis
Hospitales Universitarios Virgen del Rocío 500
Large-scale testing (Phase 3)Looking for participantsNCT05515770
What this trial is testing

The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir

Who this might be right for
HIV Infections
Evandro Chagas National Institute of Infectious Disease 1,200
Next Page